Goli Sued Over “Dreamy Sleep” Gummies That Allegedly Mislead Buyers About Melatonin Dose

Case Overview: A class action lawsuit says Goli Nutrition's Dreamy Sleep Gummies misleads buyers on melatonin dosage and value.

Consumers Affected: Shoppers who bought Goli Dreamy Sleep Gummies during the applicable time period.

Court: Supreme Court of the State of New York, County of Kings

Consumers are accusing Goli Nutrition of misrepresenting its Dreamy Sleep Gummies by overstating the number of servings and the amount of melatonin contained in each one. The case claims the label gives the impression that customers are purchasing twice the number of doses the bottle actually delivers.

At issue is how Goli markets the gummies as “5 mg per gummy” with “60 gummies” per container. Buyers say this design suggests 60 servings, but the back label lists a serving as two gummies. That means the bottle contains only 30 servings, not 60, according to the filing.

New York consumer Michael Ring filed the lawsuit, arguing that Goli’s labeling and marketing create a false sense of quantity and value. He says customers are led to believe they are getting 60 individual doses of melatonin when the product actually provides half that amount.

Label Design Said to Confuse Consumers

Ring contends that Goli’s front label omits critical serving information that would allow shoppers to make informed comparisons with other melatonin products. Competing supplements often display the serving size and dosage together on the main panel, making it easier to understand how much of an ingredient each product provides.

By contrast, the Dreamy Sleep Gummies packaging separates those details between the front and back, allegedly giving a misleading impression of potency and duration. The complaint says this design caused shoppers to overpay for a product that offered fewer servings than advertised.

Buyers Say They Paid Premium Prices for Less Product

Ring says he and other consumers spent about $14.99 per bottle based on the assumption that it contained 60 full servings. He argues that the pricing was inflated by the perception of greater quantity, and that customers would have paid less if they had known the bottle contained half as many doses.

The filing adds that Goli’s dosage claim of 5 milligrams per gummy led buyers to believe they were consuming a total of 10 milligrams of melatonin per serving, further contributing to confusion about strength and value.

Alleged Violations of New York Consumer Protection Laws

The lawsuit accuses Goli of violating New York’s General Business Law, which prohibits deceptive business practices, and includes a claim for unjust enrichment. It seeks restitution, statutory damages, and injunctive relief requiring Goli to correct its product labeling and marketing materials.

Ring aims to represent a proposed class of New York consumers who purchased Dreamy Sleep Gummies during the applicable limitations period.

Supplement Makers Facing Similar Labeling Disputes

Other companies have faced comparable lawsuits over how they present serving and dosage details on product packaging. Earlier this year, Procter & Gamble was accused of misleading buyers of its ZzzQuil PURE Zzzs melatonin supplements, while Force Factor was sued for allegedly overstating dosage levels in its nutrition products.

Those lawsuits argue that confusing or incomplete labeling can lead consumers to pay more for products than they otherwise would, particularly when supplement brands compete heavily on dosage and value.

Relief Sought in the Goli Case

Ring’s complaint asks the court to certify the proposed class, award damages to affected consumers, and order Goli to update its packaging to show serving and dosage information more transparently. It also seeks to stop the company from advertising Dreamy Sleep Gummies in a way that could mislead buyers about the amount of melatonin or the number of servings.

Case Details

• Lawsuit: Ring v. Goli Nutrition Inc.
• Case Number: 1:25-cv-06247
• Court: Supreme Court of the State of New York, County of Kings

Plaintiffs' Attorney

• Spencer Sheehan (Sheehan & Associates P.C.)

Do you check supplement labels closely before buying? Tell us how you compare dosage and value.